Overview

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The study evaluates impact of high dose radiation on overall survival in patients with unresectable nonmetastatic cholangiocarcinoma. The study randomizes patient between systemic chemotherapy alone and systemic chemotherapy and high dose radiation
Phase:
Phase 3
Details
Lead Sponsor:
Tata Memorial Hospital
Treatments:
Cisplatin
Gemcitabine